The reduction of NADH Ubiquinone oxidoreductase 24-and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease

被引:129
作者
Kim, SH
Vlkolinsky, R
Cairns, N
Fountoulakis, M
Lubec, G
机构
[1] Univ Vienna, Dept Pediat, A-1090 Vienna, Austria
[2] Kings Coll London, Inst Psychiat, Brain Bank, London, England
[3] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
关键词
NADH; ubiquinone oxidoreductase (complex I); Down syndrome; Alzheimer's disease; neuronal cell death;
D O I
10.1016/S0024-3205(01)01074-8
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
NADH: ubiquinone oxidoreductase (complex I), one of the most complicated multi-protein enzyme complexes, is important for energy metabolism because it is the initial enzyme of the mitochondrial respiratory chain. Deficiency of complex I is frequently found in various tissues of patients with neurodegenerative disease. Here we studied the protein levels of complex I 24- and 75-kDa subunits in several brain regions from patients with Down syndrome (DS) and Alzheimer's disease (AD). We determined protein levels of complex I 24-, 75-kDa subunits and mitochondrial marker proteins mitochondrial matrix protein P1 (hsp60) and aconitate hydratase from seven brain regions of patients with DS, AD and controls. Proteins were separated by two-dimensional (2-D) gel electrophoresis and identified by matrix-assisted laser desorption ionization mass spectrometry (MALDI-MS). Complex I 24-kDa subunit was significantly reduced in occipital cortex and thalamus in patients with DS and temporal and occipital cortices in patients with AD. Complex I 75-kDa subunit was significantly reduced in brain regions from patients with DS (temporal, occipital and caudate nucleus) and AD (parietal cortex). Reductions of two subunits of complex I may lead to the impairment of energy metabolism and result in neuronal cell death (apoptosis), a hallmark of both neurodegenerative disorders. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:2741 / 2750
页数:10
相关论文
共 36 条
[1]   Titrating the effects of mitochondrial complex I impairment in the cell physiology [J].
Barrientos, A ;
Moraes, CT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) :16188-16197
[2]   DOES IMPAIRMENT OF ENERGY-METABOLISM RESULT IN EXCITOTOXIC NEURONAL DEATH IN NEURODEGENERATIVE ILLNESSES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1992, 31 (02) :119-130
[3]   DO DEFECTS IN MITOCHONDRIAL ENERGY-METABOLISM UNDERLIE THE PATHOLOGY OF NEURODEGENERATIVE DISEASES [J].
BEAL, MF ;
HYMAN, BT ;
KOROSHETZ, W .
TRENDS IN NEUROSCIENCES, 1993, 16 (04) :125-131
[4]   AGING, ENERGY, AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1995, 38 (03) :357-366
[5]   Mitochondria, free radicals, and neurodegeneration [J].
Beal, MF .
CURRENT OPINION IN NEUROBIOLOGY, 1996, 6 (05) :661-666
[6]   MITOCHONDRIAL-FUNCTION IN PARKINSONS-DISEASE [J].
BINDOFF, LA ;
BIRCHMACHIN, M ;
CARTLIDGE, NEF ;
PARKER, WD ;
TURNBULL, DM .
LANCET, 1989, 2 (8653) :49-49
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   APOPTOSIS AND INCREASED GENERATION OF REACTIVE OXYGEN SPECIES IN DOWNS-SYNDROME NEURONS IN-VITRO [J].
BUSCIGLIO, J ;
YANKNER, BA .
NATURE, 1995, 378 (6559) :776-779
[9]   APOPTOSIS AND DNA-DEGRADATION INDUCED BY 1-METHYL-4-PHENYLPYRIDINIUM IN NEURONS [J].
DIPASQUALE, B ;
MARINI, AM ;
YOULE, RJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (03) :1442-1448
[10]   Identification of proteins by matrix-assisted laser desorption ionization mass spectrometry following in-gel digestion in low-salt, nonvolatile buffer and simplified peptide recovery [J].
Fountoulakis, M ;
Langen, H .
ANALYTICAL BIOCHEMISTRY, 1997, 250 (02) :153-156